GUNA-ADDICT2 by GUNA Biotherapeutics
Italian Homeopathic Remedies of the Highest Quality

GUNA-ADDICT2 by GUNA Biotherapeutics

Your Price: $26.85
Not for Sale - contact us for suggestions
Part Number:GUN_024318_030ML(DRP)0

New Customers Please Register (Create a New Account) or Existing Customers Please Login

Click Here to Login to your account or Click Here to Create Your Account.

This information is for professional and patient educational use only and is not meant to diagnose, treat, cure, prevent any disease or replace traditional treatment, and has not been evaluated by the FDA
 photo Special-Order-shipping-sm.jpg
NOTE: THIS PRODUCT HAS BEEN DISCONTINUED BY MANUFACTURER. PLEASE CONTACT DR. HALE, AP FOR ALTERNATIVE SUGGESTIONS

GUNA-ADDICT 2
 
ORAL PRODUCTS
Oral drops 30 ml / 1.0 fl oz
For the temporary relief of stressful symptoms related to nicotine withdrawal such as: irritability, inability to concentrate, sleep disturbance

Guna Addict 2 is an adjunctive product to Guna Addict 1 and provides homeopathic support factors for Antidepressant Action, Sedative Action and Tonic Action
Both of these products are used in weaning from tobacco and other products with addictive properties

Guna-Addict 1 and Guna-Addict 2 are two innovative homeopathic medicines designed to help smokers to wean from tobacco and to reduce the symptoms that often emerge during this difficult period.

Mechanisms of activity:
The homeopathic potencies of Nicotinum and Tabacum increasingly detoxify the body, making the patient more and more responsive to the toxicological activity of these two substances. With time, there will be a reduction in the daily demand for nicotine.

Detoxification of the toxic catabolites of nicotine, alcohol, coffee, opiates.
Control of the psychological addiction to the smoke of cigarette.
Mental, neurovegetative and physical symptomatology modulation.

This information is for professional and patient educational use only and is not meant to diagnose, treat, cure, prevent any disease or replace traditional treatment, and has not been evaluated by the FDA